Alternatives to EMRIS Pharma

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

AI-powered blood test for early cancer detection and subtyping.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Omnix Medical is developing a novel platform for advanced wound care management.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Developing novel therapeutic approaches for ocular diseases.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.